Financial Year |
March 31 2023 |
Monetary Funds |
58,975,173,000.00 |
Held-for-trading Financial Assets |
7,949,326,000.00 |
Notes Receivable |
5,609,072,000.00 |
Accounts Receivable |
35,551,438,000.00 |
Advances to Suppliers |
3,893,601,000.00 |
Other Receivables |
2,968,564,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
33,356,961,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
45,553,373,000.00 |
Other Current Assets |
42,421,081,000.00 |
Total Current Assets |
274,177,678,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
567,323,000.00 |
Long-term Equity Investment |
5,168,584,000.00 |
Investment Properties |
789,097,000.00 |
Fixed Assetes |
26,287,025,000.00 |
Under-construction Projects |
4,042,591,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
16,690,265,000.00 |
R&D expenses |
-- |
Goodwill |
28,733,337,000.00 |
Long-Term Deferred and Prepaid Expenses |
1,586,401,000.00 |
Deferred Income Tax Assets |
11,081,497,000.00 |
Other Non-Current Assets |
51,760,180,000.00 |
Sub-Total of Non-Current Assets |
166,909,481,000.00 |
Total Assets |
441,087,159,000.00 |
Short-Term Loans |
14,191,536,000.00 |
Trading Financial liabilities |
1,595,723,000.00 |
Notes Payable |
18,237,381,000.00 |
Accounts Payable |
66,320,879,000.00 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
4,617,834,000.00 |
Taxes Payable |
5,887,653,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,466,566,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,846,488,000.00 |
Other Current Liabilities |
64,251,434,000.00 |
Sub-Total of Current Liabilities |
222,171,111,000.00 |
Long-term Loans |
43,769,565,000.00 |
Bonds Payable |
3,098,329,000.00 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
407,856,000.00 |
Deferred Income Tax Liabilities |
4,720,248,000.00 |
Other Non-Current Liabilities |
680,516,000.00 |
Sub-Total of Non-Current Liabilities |
57,471,313,000.00 |
Total Liabilities |
279,642,424,000.00 |
Paid-In Capital(Or Share Stock) |
7,024,197,000.00 |
Capital Surplus |
21,267,192,000.00 |
Surplus Reserve |
10,702,928,000.00 |
LESS:Treasury Stock |
14,933,944,000.00 |
Undistributed Profits |
127,737,747,000.00 |
Minority Stockholder's Interest |
9,092,397,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
152,352,338,000.00 |
Owner's Equity(Stockholder's Equity) |
161,444,735,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
441,087,159,000.00 |